Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

Journal article

Peer reviewed

J Compston, D M Reid, J Boisdron, M-L Brandi, N Burlet, D Cahall, P D Delmas, W Dere, J-P Devogelaer, L A Fitzpatrick, …

Osteoporosis international, Vol.19(9), pp.1247-1250

01/09/2008

PMID: 18604578

Abstract

Bone Density - drug effects

Bone Density Conservation Agents - therapeutic use

Clinical Trials as Topic

Drug Approval - methods

Female

Glucocorticoids - adverse effects

Humans

Male

Osteoporosis - chemically induced

Osteoporosis - drug therapy

Osteoporosis - prevention & control

Research Design

Sex Factors

1 Record Views

Title: Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science
Creators - without role: J Compston - University of Cambridge
D M Reid - University of Aberdeen
J Boisdron - Roche
M-L Brandi - University of Florence
N Burlet
D Cahall - Sanofi
P D Delmas - Inserm
W Dere - Amgen
J-P Devogelaer - UCLouvain
L A Fitzpatrick - GlaxoSmithKline
B Flamion - University of Namur
N Goel - UCB Pharma
S Korte - Novartis
A Laslop
B Mitlak - Eli Lilly
S Ormarsdottir
J Ringe - Klinikum Leverkusen
R Rizzoli - University Hospital of Geneva
Y Tsouderos - Servier
T Van Staa
J-Y Reginster - University of Liège
Group for the Respect of Ethics and Excellence in Science
Publication Details: Osteoporosis international, Vol.19(9), pp.1247-1250
Identifiers: 9946887508331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article